Crystals of the indoloquinoline alkaloid cryptolepine complexed with the DNA fragment d(CCTAGG) 2 have been grown by the hangingdrop technique at 293 K using ammonium sulfate as the precipitating agent. Over a period of three weeks, yellow tapering bullet-shaped crystals grew to maximum dimensions of 0.2 Â 0.1 Â 0.1 mm. The crystals belong to space group P6 4 , with unit-cell parameters a = b = 29.960, c = 39.64 A Ê , = = 90, = 120
Introduction
Cryptolepine (Fig. 1) [5-methylquinolo-(2 H ,3 H ,3,2)-indole] is an indoloquinoline alkaloid isolated from the roots of the West African shrub Cryptolepis sanguinolenta. This natural product was ®rst isolated from the roots of C. triangularis collected in Kisantu (Democratic Republic of Congo). Extracts of the roots of C. sanguinolenta are used clinically in Ghana for the treatment of malaria (Boye & Ampofo, 1983) . Extracts have also been used as a remedy against colic, as a stomach ulcer tonic and cryptolepine itself has been found to produce a variety of pharmacological effects; these include hypotensive and antipyretic properties (Raymond-Hamet, 1937 , 1938 Noamesi & Bamgbose, 1980) , presynaptic -adrenoreceptor blocking action (Noamesi & Bamgbose, 1982) , anti-muscarinic properties (Rauwald et al., 1992) , anti-in¯ammatory properties (Bamgbose & Noamesi, 1981) and antibacterial effects (Boakye-Yiadom & Heman-Ackah, 1979; Paulo, Pimentel et al., 1994; Cimanga et al., 1996) .
Cryptolepine has potent in vitro activity against malaria parasites (Plasmodium falciparum) (Kirby et al., 1995; Grellier et al., 1996; Wright et al., 1996; Cimanga et al., 1997) and possesses cytotoxic activity, inhibiting DNA synthesis in B16 melanoma cells (Bonjean et al., 1998) . The compound has also been shown to form a complex with haematin in cell-free systems, suggesting that it has a quinine-like mode of action (Wright et al., 1996) . An understanding of the way in which cryptolepine combines with DNA will assist in the rational design of antimalarial compounds which inhibit -haematin formation but which, unlike cryptolepine, do not intercalate into DNA. Derivatives of cryptolepine are currently being evaluated as leads to selective antimalarial agents (Wright et al., 1997) . More recently, the results of various studies (Bonjean et al., 1998) have revealed that the alkaloid binds tightly to DNA and behaves as a typical intercalating agent. It was found that the drug interacts preferentially with GC-rich sequences and discriminates against homo-oligomeric runs of A and T. The study also led to the discovery that cryptolepine is a potent topoisomerase II inhibitor and a promising antitumour agent. It stabilizes topoisomerase II±DNA covalent complexes and stimulates the cutting of DNA at a subset of pre-existing topoisomerase II cleavage sites. The intercalating properties of cryptolepine are worthy of investigation as this compound may be a potential lead to new anticancer drugs. The determination of its structure was based on chemical reactions of a degradative nature and on ultraviolet spectroscopy in neutral and basic media.
1 H NMR, 13 C NMR and MS data have con®rmed the proposed structure (DwumaBadu et al., 1978; Ablordeppey et al., 1990; Tackie et al., 1991) . A recent crystallographic study of the cryptolepine±tetraphenyl borate complex has also con®rmed the structure and revealed a unique packing propensity (Wright et al., 1999) . crystallization papers
Methods and results
Cryptolepine was isolated from the roots of C. sanguinolenta as described in detail elswhere (Wright et al., 1996) . Crystallization conditions were screened using the Natrix Screen (Hampton Research, USA) and the Nucleic Acid Mini Screen (Berger et al., 1996) . Crystals were grown at 293 K by the hanging-drop vapour-diffusion technique using Linbro multiwell tissue-culture plates. Crystals grew to a maximum size after about three weeks on mixing 0.5 ml 5 mM cryptolepine hydrochloride and 0.5 ml 3 mM d(CCTAGG) 2 with either 1.0 ml of crystallization solution containing 5 mM magnesium acetate, 25 mM MES pH 6.5 and 1.25 M ammonium sulfate or 2 ml of crystallization solution containing 5 mM magnesium sulfate, 25 mM sodium cacodylate pH 6.5 and 1 M ammonium sulfate. Yellow bulletshaped crystals grew to maximum dimensions of 0.2 Â 0.1 Â 0.1 mm (Fig. 2) and diffracted weakly on an in-house rotatinganode generator. Synchrotron radiation was therefore essential for the success of this project. Crystals were¯ash-frozen in a stream of evaporating liquid nitrogen at 120 K. Diffraction data were collected at EMBL beamline BW7A (Hamburg, Germany) to 1.4 A Ê resolution using a MAR Research image-plate detector and a wavelength of 1.1 A Ê (see Table 1 ).
Determination of unit-cell parameters and space group and the integration of re¯ection intensities were performed using DENZO (Otwinowski, 1993) and the data were scaled using SCALEPACK (Otwinowski, 1993). The structure determination of the cryptolepine±d(CCTAGG) 2 complex is in progress. Crystal of the cryptolepine±(CCTAGG) 2 complex used for data collection. 
